The coronary stent market is experiencing substantial growth, with a valuation of USD 8.99 billion in 2023. This value is expected to rise to USD 12.51 billion by 2032, representing a 3.6% Compound Annual Growth Rate (CAGR) from 2024 to 2032.
Key Findings:
- Drug-eluting stents (DES) held a commanding 60% share of the market in 2023.
- North America led the market in 2023, accounting for 37%.
- Bioresorbable Scaffold Systems (BRS) are anticipated to exhibit the highest growth rate, with a projected CAGR of 5.2% over the forecast period.
- Coronary stents are predominantly used in coronary artery diseases, which is the primary driver of the coronary stent market.
Download a short version of this report @ https://www.towardshealthcare.com/personalized-scope/5152
Overview:
Coronary stents are vital medical devices commonly employed in angioplasty procedures, aimed at opening clogged coronary arteries due to coronary artery disease (CAD). These stents are utilized when coronary arteries become obstructed by underlying atherosclerosis disease. This procedure, known as percutaneous coronary intervention (PCI), has revolutionized the treatment of coronary artery disease since its inception in the late 1980s with the development of the first balloon-expandable stents. These devices have significantly altered the treatment landscape for CAD, the leading cause of death globally.
CAD arises from the buildup of plaque in the coronary arteries, leading to restricted blood flow to the heart, which can result in chest pain (angina), heart attacks, and heart failure.
Previously, the conventional treatment for CAD involved bypass surgery, an invasive procedure. However, coronary stents, small expandable mesh tubes, are now inserted into narrowed coronary arteries to keep them open and enhance blood flow.
Percutaneous coronary intervention (PCI), also referred to as angioplasty with stenting, is a minimally invasive procedure that employs catheters to deliver and implant the stent.
What Are Coronary Stents?
Coronary stents are small, expandable tubes made of metal mesh. They are used to prop open narrowed or blocked arteries in the heart, allowing blood to flow freely.
Types of Coronary Stents
- Drug-Eluting Stents (DES): These stents are coated with medications that help prevent the artery from becoming blocked again.
- Bare-Metal Stents (BMS): These stents are not coated with medication and are primarily used in patients who cannot tolerate DES.
- Bioabsorbable Stents: These stents slowly dissolve over time, leaving behind natural vessel tissue.
Market Growth Drivers
Increasing Prevalence of Cardiovascular Diseases
- Cardiovascular diseases (CVDs), including coronary artery disease, are among the leading causes of mortality worldwide. The rising incidence of CVDs is a significant driver of the coronary stent market.
Technological Advancements
- Advancements in stent technology have led to the development of innovative products with improved efficacy and safety profiles. For instance, the introduction of bioabsorbable stents has reduced the risk of long-term complications associated with traditional stents.
Aging Population
- The aging population is more susceptible to cardiovascular diseases, thereby increasing the demand for coronary stents. As life expectancy rises, the prevalence of CVDs is expected to grow, further driving market growth.
Increasing Adoption of Minimally Invasive Procedures
- Minimally invasive procedures, such as percutaneous coronary intervention (PCI), have become preferred options for treating coronary artery disease. These procedures involve smaller incisions, shorter recovery times, and reduced risks compared to traditional open-heart surgeries, driving the demand for coronary stents.
Coronary Stent Market Segments
(**We also provide cross-sectional analysis in market segments)
By Type
- Bare Metal Stents (BMS)
- Drug-eluting Stents (DES)
- Bioresorbable Scaffold System (BRS)
- Drug-eluting Balloons (DEB)
By End Use
- Hospitals & Ambulatory Surgical Centers
- Specialty Clinics
- Others
By Geography
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- South America
To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5152
Read more about Coronary Stent Industry
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
About Us
Healthcare Web Wire is a premier subsidiary of Towards Healthcare, dedicated to providing comprehensive insights and information related to the healthcare industry. With a commitment to delivering accurate and timely updates, Healthcare Web Wire serves as a vital resource for professionals, enthusiasts, and stakeholders within the healthcare sector. Our platform serves as a central hub for the latest news, trends and developments shaping the healthcare landscape. Join us on Healthcare Web Wire and become part of a vibrant community dedicated to advancing healthcare knowledge and shaping the future of healthcare worldwide.
Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
